The new drug application for TLX007-CDx has been approved by the FDA for patients with prostate cancer.
Approval Alert | TXL007-CDx in Prostate Cancer
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer
2
Japan Approves T-DXd Combo and Dato-DXd for First-Line Metastatic Breast Cancer
3
Fixed-Duration Combinations and MRD-Guided Therapy as Emerging Priorities in CLL
4
FDA Clears Triton Robotic Endoscopy System for Colon Procedures
5